Guido Rovera

413 total citations
25 papers, 208 citations indexed

About

Guido Rovera is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Guido Rovera has authored 25 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Guido Rovera's work include Medical Imaging Techniques and Applications (8 papers), Prostate Cancer Treatment and Research (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Guido Rovera is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Prostate Cancer Treatment and Research (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Guido Rovera collaborates with scholars based in Italy, France and Russia. Guido Rovera's co-authors include Raffaele Pellerito, Orazio Schillaci, Alessio Rizzo, Massimo Salvatori, Luca Indovina, Patrizia D’Amelio, Simone Parisi, Francesca Sassi, Ilaria Buondonno and Désirèe Deandreis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Guido Rovera

23 papers receiving 205 citations

Peers

Guido Rovera
Giulia Zumbo United Kingdom
E HENDERSON United Kingdom
Casper Eurlings Netherlands
J. Bleck Germany
Guido Rovera
Citations per year, relative to Guido Rovera Guido Rovera (= 1×) peers G. Arcangeli

Countries citing papers authored by Guido Rovera

Since Specialization
Citations

This map shows the geographic impact of Guido Rovera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Rovera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Rovera more than expected).

Fields of papers citing papers by Guido Rovera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Rovera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Rovera. The network helps show where Guido Rovera may publish in the future.

Co-authorship network of co-authors of Guido Rovera

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Rovera. A scholar is included among the top collaborators of Guido Rovera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Rovera. Guido Rovera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rovera, Guido, Séréna Grimaldi, Marco Oderda, et al.. (2024). Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy. Diagnostics. 14(17). 1964–1964. 5 indexed citations
2.
Dondi, Francesco, Alberto Miceli, Guido Rovera, et al.. (2024). Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?. Bioengineering. 11(7). 714–714. 2 indexed citations
3.
Grimaldi, Séréna, Guido Rovera, Roberto Passera, et al.. (2024). Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT). La radiologia medica. 130(2). 271–279.
4.
Rovera, Guido, Luca Urso, Riccardo Laudicella, et al.. (2024). Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2. Clinical and Translational Imaging. 12(6). 743–754. 1 indexed citations
5.
Rovera, Guido, Luca Urso, Riccardo Laudicella, et al.. (2024). Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting. Clinical and Translational Imaging. 12(6). 769–785. 1 indexed citations
6.
Raffa, Stefano, Nicola Girtler, Matteo Pardini, et al.. (2024). Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 68(3). 187–193.
7.
Rovera, Guido, Mario Levis, Alessia Pellerino, et al.. (2024). [18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 68(3). 200–206. 1 indexed citations
8.
Rovera, Guido, Séréna Grimaldi, Marco Oderda, et al.. (2023). Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study. Diagnostics. 13(18). 3013–3013. 6 indexed citations
10.
Fassio, Angelo, Fabiola Atzeni, Maurizio Rossini, et al.. (2023). Osteoimmunology of Spondyloarthritis. International Journal of Molecular Sciences. 24(19). 14924–14924. 3 indexed citations
11.
Rovera, Guido, Vittoria Rufini, Francesco Giammarile, et al.. (2023). 99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3375–3389. 7 indexed citations
13.
Rovera, Guido, Piero Fariselli, & Désirèe Deandreis. (2022). Development of a REDCap-based workflow for high-volume relational data analysis on real-time data in a medical department using open source software. Computer Methods and Programs in Biomedicine. 226. 107111–107111. 5 indexed citations
14.
Rovera, Guido, Séréna Grimaldi, Roberto Passera, et al.. (2022). Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence. Diagnostics. 12(6). 1309–1309. 6 indexed citations
15.
Ceci, Francesco, Guido Rovera, Giuseppe Carlo Iorio, et al.. (2022). Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy. European Journal of Nuclear Medicine and Molecular Imaging. 49(9). 3257–3268. 17 indexed citations
16.
Rovera, Guido, et al.. (2020). Correlation between parotid saliva composition and dental caries using 31P-NMR and ICDAS score. Archives of Oral Biology. 111. 104651–104651. 5 indexed citations
17.
Salvatori, Massimo, Alessio Rizzo, Guido Rovera, Luca Indovina, & Orazio Schillaci. (2019). Radiation dose in nuclear medicine: the hybrid imaging. La radiologia medica. 124(8). 768–776. 30 indexed citations
18.
Crepaldi, G., et al.. (2019). Osteopoikilosis hiding active sacroiliitis in Psoriatic Arthritis. Lara D. Veeken. 58(11). 1922–1922. 1 indexed citations
19.
Buondonno, Ilaria, Guido Rovera, Francesca Sassi, et al.. (2017). Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study. PLoS ONE. 12(6). e0178463–e0178463. 43 indexed citations
20.
Varisco, V., Mauro Viganò, Alberto Batticciotto, et al.. (2016). Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study. The Journal of Rheumatology. 43(5). 869–874. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026